Matrix Shuttle Delivery Devices for Environmental Remediation and Human Health
Legal Citation
Summary of the Inventive Concept
The inventive concept applies the core technology of matrix shuttle delivery devices to new applications in environmental remediation, aquaculture, wastewater treatment, bioremediation, and human health, enabling the targeted release of beneficial microorganisms to address pressing ecological and health challenges.
Background and Problem Solved
The original patent addressed the limited capacity for spontaneous repair of chondral lesions in cartilage tissue. However, this technology has broader implications and can be adapted to tackle pressing environmental and health issues. The inventive concept addresses the limitations of existing solutions in environmental remediation, aquaculture, wastewater treatment, bioremediation, and human health, which often rely on inefficient or ineffective methods for introducing beneficial microorganisms.
Detailed Description of the Inventive Concept
The matrix shuttle delivery device is adapted for releasing beneficial microorganisms in various environments, including aquaculture, wastewater, contaminated soil, agricultural settings, and the human gut. The device comprises a shuttle body, a delivery tip, and a plunger, which can be modified to accommodate specific microorganisms and deployment requirements. The system may also include sensors, control units, and monitoring systems to optimize the release and tracking of beneficial microorganisms. In each application, the matrix shuttle delivery device enables targeted and efficient introduction of beneficial microorganisms, promoting healthy ecosystems, degrading pollutants, and improving human health.
Novelty and Inventive Step
The inventive concept introduces a new paradigm for applying matrix shuttle delivery devices to environmental remediation and human health, leveraging the core technology to address unmet needs in these fields. The new claims are novel and non-obvious compared to the original patent, as they require a deep understanding of the interplay between microorganisms, ecosystems, and human health.
Alternative Embodiments and Variations
Alternative embodiments may include modifying the matrix shuttle delivery device for specific microorganisms, incorporating additional components for real-time monitoring, or developing miniaturized versions for in vivo applications. Variations may include adapting the device for use in different environmental settings, such as marine ecosystems or agricultural fields.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including environmental remediation, aquaculture, wastewater treatment, bioremediation, and human health. The target market includes companies, research institutions, and government agencies seeking innovative solutions for ecological and health challenges.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B10/02 |
| A | A61 | A61B17/3468 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical device engineering, focusing on targeted delivery systems and microorganism deployment technologies, with expertise in medical device design, microbial delivery mechanisms, and precision engineering
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or biotech specialist with advanced degree, understanding of medical device design, microorganism delivery techniques, and experience in developing targeted release systems for biological applications
Obviousness Rationale
A PHOSITA would recognize the fundamental design principles of the matrix shuttle delivery device can be readily adapted to alternative applications by modifying the delivery mechanism, payload, and monitoring systems. The core technological concept of a controlled release mechanism with a shuttle body, delivery tip, and plunger represents a versatile platform that can be systematically extended to different environmental and biological contexts. The variations disclosed in the PTD represent predictable engineering adaptations that leverage the fundamental mechanical and biological principles established in the source patent.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,170 |
|---|---|
| Title | Methods and devices for repairing cartilage defects |
| Assignee(s) | Vericel Corporation |